Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study

被引：0
作者：
Emily C. L. Wong
Shahin Merat
Cristina Monaco
Parambir S. Dulai
Vipul Jairath
John K. Marshall
Walter Reinisch
Neeraj Narula
机构：
[1] McMaster University,Department of Medicine (Division of Gastroenterology) and Farncombe Family Digestive Health Research Institute
[2] Northwestern University,Division of Gastroenterology
[3] Western University,Division of Gastroenterology, Department of Medicine
[4] Medical University of Vienna,Division of Gastroenterology and Hepatology, Department of Internal Medicine III
[5] McMaster University Medical Centre,undefined
来源：
Digestive Diseases and Sciences | 2023年 / 68卷
关键词：
Ulcerative colitis; Inflammatory bowel disease; Infliximab; Tofacitinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2635 / 2646
页数：11
相关论文
共 82 条
  • [1] Cury DB(2009)Infliximab to treat severe ulcerative colitis World J Gastroenterol. 15 1771-3
  • [2] MeS Cury(2020)AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis Gastroenterology 47 162-175
  • [3] Elias GV(2018)Systematic review with network meta-analysis: first- and second-line pharmacotherapy for moderate-severe ulcerative colitis Alimentary Pharmacology & Therapeutics. 99 e22894-328
  • [4] Mizsputen SJ(2020)Efficacy of infliximab, cyclosporine and tacrolimus on ulcerative colitis: A meta-analysis Medicine (Baltimore). 34 318-465
  • [5] Feuerstein JD(2016)The mechanism of action of tofacitinib-an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis Clin Exp Rheumatol. 12 1756284819848631-170
  • [6] Isaacs KL(2019)Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience Therap Adv Gastroenterol. 47 454-9
  • [7] Schneider Y(2018)Systematic review with network meta-analysis: comparative assessment of tofacitinib and biological therapies for moderate-to-severe ulcerative colitis Alimentary Pharmacology & Therapeutics. 7 161-2476
  • [8] Singh S(2021)Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis Gut 7 373-1736
  • [9] Fumery M(2022)Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis Lancet Gastroenterol Hepatol. 353 2462-471
  • [10] Sandborn WJ(2019)Tofacitinib for the treatment of ulcerative colitis: A review of the literature World J Meta-Anal. 376 1723-424
123456789